(NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for TALZENNA ® (talazoparib), an oral poly ...
The dollar largely stabilized on Thursday as renewed U.S.-Iran tensions kept investors on edge and underpinned demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results